Stock listing

Stuttgart:TE1 Bio-Techne Corp Aktie

German listing (Stuttgart) of Bio-Techne Corp · home listing NASDAQ:TECH

Follow Bio-Techne Corp into a list and get an email when it puts out news.

Home listing price · NASDAQ:TECH

$72.67 USD -0.08 (-0.1%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:TECH

Past year +23.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$72.66 – $72.77 USDNov 20, 2026
Volume
3.66M sharesNov 20, 2026
Market cap
$11.41B USDAt the close on Nov 20, 2026 · price × 157.1M shares outstanding
52-week range
$43.20 – $72.88 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$209.7M USDMedian day 2.71M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Bio-Techne Corp logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:TECH · Home$72.67 USD-0.08 (-0.1%)3,663,174$72.74$72.77$72.66$72.75Close on Nov 20, 2026
B3:T1CH3413.38 BRL0.00 (0.0%)—13.3813.3813.3813.38Close on Nov 19, 2026
Frankfurt:TE1€65.82 EUR-1.18 (-1.8%)10€64.88€65.82€64.88€67.00Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:TECH · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$72.67-0.08-0.1%$72.74$72.77$72.663,663,174
$72.75+0.12+0.2%$72.67$72.81$72.672,628,447
$72.63-0.16-0.2%$72.80$72.86$72.595,694,130
$72.79-0.010.0%$72.76$72.85$72.713,502,601
$72.80-0.04-0.1%$72.83$72.84$72.732,270,244
$72.84+0.04+0.1%$72.80$72.86$72.802,191,734
$72.80-0.020.0%$72.83$72.83$72.732,606,619
$72.82-0.010.0%$72.79$72.85$72.783,239,564
$72.83+0.05+0.1%$72.83$72.88$72.762,668,038
$72.78+0.12+0.2%$72.68$72.80$72.631,973,814
$72.66-0.07-0.1%$72.80$72.80$72.664,506,691
$72.73+0.07+0.1%$72.73$72.83$72.714,206,586
$72.66-0.010.0%$72.72$72.72$72.633,511,852
$72.67+0.010.0%$72.69$72.73$72.662,016,334
$72.66-0.05-0.1%$72.72$72.73$72.662,565,846
$72.71+0.020.0%$72.64$72.73$72.642,888,022
$72.69+0.09+0.1%$72.62$72.72$72.622,719,670
$72.60-0.09-0.1%$72.61$72.75$72.602,429,343
$72.69+0.14+0.2%$72.63$72.72$72.562,464,603
$72.55-0.07-0.1%$72.60$72.63$72.551,898,400
$72.62-0.020.0%$72.56$72.69$72.514,160,500
$72.64+0.06+0.1%$72.54$72.65$72.503,497,700
$72.58+0.09+0.1%$72.48$72.61$72.483,210,400
$72.49-0.08-0.1%$72.51$72.55$72.472,573,900
$72.57+0.05+0.1%$72.59$72.59$72.452,646,300
$72.52+0.020.0%$72.53$72.61$72.502,403,800
$72.50+0.020.0%$72.50$72.54$72.481,544,800
$72.48-0.08-0.1%$72.49$72.55$72.482,420,600
$72.56+0.10+0.1%$72.47$72.59$72.442,419,600
$72.46+0.010.0%$72.46$72.52$72.442,228,000
$72.45-0.08-0.1%$72.56$72.58$72.435,390,300
$72.53+0.10+0.1%$72.43$72.55$72.433,153,500
$72.43-0.15-0.2%$72.58$72.61$72.412,893,100
$72.58+0.18+0.2%$72.41$72.61$72.382,087,200
$72.400.000.0%$72.44$72.47$72.381,866,700
$72.40-0.07-0.1%$72.50$72.54$72.382,711,400
$72.47+0.09+0.1%$72.38$72.55$72.333,138,700
$72.38-0.13-0.2%$72.36$72.50$72.363,360,200
$72.51-0.10-0.1%$72.58$72.65$72.493,820,200
$72.61+0.04+0.1%$72.59$72.64$72.562,176,000
$72.57+0.05+0.1%$72.54$72.63$72.512,986,200
$72.52-0.030.0%$72.50$72.64$72.483,562,200
$72.55+0.08+0.1%$72.52$72.69$72.463,441,500
$72.47+0.10+0.1%$72.50$72.54$72.444,667,000
$72.37-0.04-0.1%$72.41$72.44$72.265,019,500
$72.41+0.08+0.1%$72.36$72.48$72.283,784,600
$72.33-0.010.0%$72.35$72.37$72.223,650,100
$72.34+0.07+0.1%$72.28$72.39$72.212,930,000
$72.27+0.15+0.2%$72.21$72.30$72.172,740,200
$72.12+0.04+0.1%$72.15$72.38$72.122,723,700
$72.08-0.17-0.2%$72.28$72.33$72.083,817,800
$72.25-0.06-0.1%$72.30$72.37$72.231,987,200
$72.31-0.12-0.2%$72.37$72.46$72.292,066,700
$72.43-0.020.0%$72.40$72.48$72.401,856,300
$72.45+0.15+0.2%$72.36$72.58$72.322,542,800
$72.30+0.12+0.2%$72.20$72.38$72.201,655,800
$72.18-0.13-0.2%$72.36$72.39$72.142,903,300
$72.31-0.04-0.1%$72.38$72.41$72.302,200,600
$72.35-0.12-0.2%$72.40$72.48$72.321,630,500
$72.47+0.09+0.1%$72.38$72.50$72.351,683,900
$72.38+0.05+0.1%$72.33$72.40$72.331,386,300
$72.33-0.06-0.1%$72.35$72.38$72.281,898,209
$72.39+0.07+0.1%$72.29$72.42$72.272,001,603
$72.32+0.04+0.1%$72.32$72.35$72.273,958,000
$72.28-0.20-0.3%$72.36$72.51$72.233,540,100

Splits

3 splits since 1997 · NASDAQ:TECH · every price before a split is adjusted for it

DayRatioWhat
4-for-1Split
2-for-1Split
2-for-1Split
Ticker
Stuttgart:TE1
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Stuttgart
Currency
EUR

What changed lately

Latest news

All Bio-Techne Corp news

Bio-Techne Corp on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
30 in the last 12 months · 305 in all · newest Nov 4, 2026 · oldest 2019
Calls
27 calls with a replay · 27 with a transcript · latest May 6, 2026
Decks
16 decks · latest January 2026

Where Bio-Techne Corp is listed

ListingExchangeCountryCurrency
NASDAQ:TECH · Home listingNASDAQUnited StatesUSD
gettex:TE1gettexGermanyEUR
LS Exchange:A12ENGLS ExchangeGermanyEUR
BIVA:TECHBIVAMexicoMXN
B3:T1CH34B3BrazilBRL
BMV:TECHBMVMexicoMXN
Lang & Schwarz:A12ENGLang & SchwarzGermanyEUR
Milan:1TECHMilanItalyEUR
BOATS:TECHBOATSUnited StatesUSD
Stuttgart:TE1 · This pageStuttgartGermanyEUR
Dusseldorf:TE1DusseldorfGermanyEUR
Tradegate:TE1TradegateGermanyEUR
Frankfurt:TE1FrankfurtGermanyEUR
Hamburg:TE1HamburgGermanyEUR
Munich:TE1MunichGermanyEUR
Hanover:TE1HanoverGermanyEUR
Xetra:TE1XetraGermanyEUR

Valuation

P/E 66.4× against a median of 32.1×: 7th lowest of 8 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$11.35B USD
P/E
66.4×
EV/sales
9.2×
EV/EBITDA
33.6×
Price/book
5.3×
Gross margin
65.8%
Operating margin
19.6%
Net margin
14.0%
Debt to equity
0.1×
Beta vs S&P 500
0.54

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Bio-Techne Corp · NASDAQ:TECHUS$11.41BUS$11.35B66.4×9.2×33.6×5.3×14.0%0.1×0.54
Charles River Laboratories International, Inc. · NYSE:CRLUS$15.06BUS$14.86B375×3.7×33.5×4.7×1.0%0.0×1.23
ICON plc · NASDAQ:ICLRUS$14.41BUS$16.98B32.1×2.1×15.7×1.6×5.5%0.4×1.08
bioMerieux SA · EURONEXT:BIMUS$11.79BUS$11.53B27.0×2.6×10.9×2.5×9.8%0.1×n/a
Qiagen N.V. · NYSE:QGENUS$10.18BUS$11.03B24.9×5.3×15.0×3.0×19.5%0.5×0.33
Avantor, Inc. · NYSE:AVTRUS$10.06BUS$13.28B29.8×2.0×14.7×1.7×5.1%0.6×0.78
WuXi XDC Cayman, Inc. · HKEX:2268US$9.64BUS$8.87B43.4×9.9×33.4×5.7×24.9%0.1×n/a
Tempus AI, Inc. · NASDAQ:TEMUS$9.58BUS$8.99Bn/a6.0×n/a19.1×−12.5%0.0×2.51
Bruker Corporation · NASDAQ:BRKRUS$8.62BUS$10.22Bn/a2.9×64.4×3.7×−3.5%0.7×1.72
Pharmaron Beijing Co., Ltd. Class A · SZSE:300759US$8.54BUS$8.25B32.1×3.4×n/a3.4×11.1%0.1×n/a
GenScript Biotech Corporation · HKEX:1548US$8.08BUS$7.50Bn/a7.8×22.8×2.1×−55.5%0.1×n/a
Median of the othersUS$9.85BUS$10.62B32.1×3.6×19.2×3.2×5.3%0.1×1.16

Forecasts

12 hold · 1 strong sell · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
70.50 USD · Analysts' mean
EPS, year to Jun 2027
2.01 · 9 analysts
Revenue, year to Jun 2027
1.27B · 11 analysts

Team and board

Officers

OfficerRole
Steve CrousePresident, Diagnostics and Spatial Biology Segment
David ClairVice President, Investor Relations

Board

DirectorRole
Alpna SethDirector
Amy E. HerrDirector
John L. HigginsDirector
Joseph D. KeeganDirector
Judith KlimovskyDirector
Julie L. BushmanDirector
Robert V. BaumgartnerDirector
Rupert VesseyDirector

Events

Calls

CallWhenStatus
Bio-Techne (NASDAQ:TECH) Q3 2026 Earnings CallWed, May 06, 2026 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q2 2026 Earnings CallWed, Feb 04, 2026 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q1 2026 Earnings CallWed, Nov 05, 2025 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q4 2025 Earnings CallWed, Aug 06, 2025 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q3 2025 Earnings CallWed, May 07, 2025 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q2 2025 Earnings CallWed, Feb 05, 2025 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q1 2025 Earnings CallWed, Oct 30, 2024 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q4 2024 Earnings CallWed, Aug 07, 2024 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q3 2024 Earnings CallWed, May 01, 2024 · 8:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q2 2024 Earnings CallThu, Feb 01, 2024 · 9:00 AM ETReplay
All 27 calls
CallWhenStatus
Bio-Techne (NASDAQ:TECH) Q1 2024 Earnings CallTue, Oct 31, 2023 · 9:00 PM ETReplay
Bio-Techne (NASDAQ:TECH) Q4 2023 Earnings CallTue, Aug 08, 2023 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q3 2023 Earnings CallWed, May 03, 2023 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q2 2023 Earnings CallThu, Feb 02, 2023 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q1 2023 Earnings CallTue, Nov 01, 2022 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q4 2022 Earnings CallThu, Aug 04, 2022 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q3 2022 Earnings CallWed, May 04, 2022 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q2 2022 Earnings CallTue, Feb 01, 2022 · 8:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q1 2022 Earnings CallTue, Nov 02, 2021 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q4 2021 Earnings CallThu, Aug 05, 2021 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q3 2021 Earnings CallThu, May 06, 2021 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q2 2021 Earnings CallTue, Feb 02, 2021 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q1 2021 Earnings CallThu, Nov 05, 2020 · 9:00 AM ETReplay
Bio-Techne (NASDAQ:TECH) Q4 2020 Earnings CallTue, Aug 04, 2020Replay
Bio-Techne (NASDAQ:TECH) Q3 2020 Earnings CallFri, May 01, 2020Replay
Bio-Techne (NASDAQ:TECH) Q2 2020 Earnings CallTue, Feb 04, 2020Replay
Bio-Techne (NASDAQ:TECH) Q1 2020 Earnings CallTue, Oct 29, 2019Replay

Results days

QuarterResultsShare move
Q1 2027Nov 18, 2026+0.1%
Q4 2026Aug 12, 2026 · Before open+0.1%
Q3 2026May 6, 2026 · Before open−16.4%
Q2 2026Feb 4, 2026 · Before open+6.3%
Q1 2026Nov 5, 2025 · Before open−1.9%
Q4 2025Aug 6, 2025 · Before open−8.7%
Q3 2025May 7, 2025 · Before open+2.2%
Q2 2025Feb 5, 2025 · Before open+3.7%
Q1 2025Oct 30, 2024 · Before open+7.5%
Q4 2024Aug 7, 2024 · Before open−9.5%
All 20 quarters
QuarterResultsShare move
Q3 2024May 1, 2024 · Before open+16.2%
Q2 2024Feb 1, 2024 · Before open−2.5%
Q1 2024Oct 31, 2023 · Before open−3.5%
Q4 2023Aug 8, 2023 · Before open+3.7%
Q3 2023May 3, 2023 · Before open+7.2%
Q2 2023Feb 2, 2023 · Before open−0.5%
Q1 2023Nov 1, 2022 · Before open+4.4%
Q4 2022Aug 4, 2022 · Before open−0.2%
Q3 2022May 4, 2022 · Before open+3.2%
Q2 2022Feb 1, 2022 · Before open+6.7%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (January 2026)Investor deck14 slidesJanuary 2026
Investor Presentation (June 2025)Investor deck15 slidesJun 3, 2025
Investor Presentation (January 2025)Investor deck15 slidesJan 14, 2025
Investor Presentation (June 2024)Investor deck26 slidesJune 2024
Investor Presentation (January 2024)Investor deck26 slidesJanuary 2024
Investor Day (September 2023)Investor day125 slidesSep 8, 2023
Investor Presentation (January 2023)Investor deck29 slidesJanuary 2023
Investor Presentation (March 2022)Investor deck27 slidesMarch 2022
J.P. Morgan Healthcare Conference 2022Conference28 slidesJanuary 2022
Investor Presentation (June 2021)Investor deck22 slidesJune 2021
All 16 decks
DeckKindSlidesDate
J.P. Morgan Healthcare Conference 2021Conference17 slidesJanuary 2021
Investor Presentation (May 2020)Investor deck13 slidesMay 2020
Investor Presentation (November 2019)Investor deck10 slidesNovember 2019
Investor Day (September 2018)Investor day123 slidesSep 7, 2018
Merger or Acquisition (June 2018)Merger or acquisition18 slidesJune 2018
Investor Day (September 2016)Investor day105 slidesSep 15, 2016

Open Decks

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue1.22B1.22B1.16B1.14B1.11B931.0M738.7M714.0M643.0M563.0M
Cost of revenue416.0M429.4M389.3M366.9M349.1M298.2M255.5M240.5M210.8M188.5M
Gross profit799.1M790.3M769.7M769.8M756.5M632.9M483.2M473.5M432.1M374.5M
Research and development94.8M99.5M96.7M92.5M87.1M70.6M65.2M62.4M55.3M53.5M
Selling, general and administrative452.4M588.5M466.4M378.4M372.8M325.0M260.6M264.4M240.6M200.4M
Operating income251.9M102.3M206.7M298.9M296.6M237.3M157.4M146.7M136.2M120.6M
Depreciation and amortization97.4M109.9M111.7M107.2M101.1M87.7M82.7M78.2M64.5M60.0M
EBITDA349.2M212.2M318.4M406.2M397.7M325.0M240.2M224.9M200.6M180.6M
Interest expense9.63M8.51M15.7M11.2M11.3M14.0M19.2M21.7M10.2M7.36M
Income before tax240.7M98.5M185.7M338.7M301.4M148.2M276.5M112.0M126.0M112.0M
Income tax58.8M25.1M17.6M53.2M38.3M8.59M47.2M15.9M-198.0K35.9M
Net income181.8M73.4M168.1M285.3M272.1M140.4M229.3M96.1M126.2M76.1M
Earnings per share, basic1.170.471.071.811.730.916.002.543.362.04
Earnings per share, diluted1.160.461.051.761.660.875.822.473.312.03

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents264.7M162.2M151.8M180.6M172.6M199.1M146.6M100.9M122.0M91.6M
Short-term investments01.07M23.7M74.5M32.5M124.3M65.1M59.8M66.1M
Receivables216.6M206.9M241.4M218.5M194.5M145.4M122.5M137.5M120.3M116.8M
Inventory195.7M189.4M179.7M171.6M141.1M116.7M103.2M91.0M85.6M85.6M
Current assets744.4M608.3M617.4M621.5M605.6M510.6M520.9M412.6M398.4M348.0M
Property, plant and equipment231.8M245.7M251.2M226.2M223.2M207.9M176.8M154.0M145.3M135.1M
Goodwill975.4M980.9M972.7M872.7M822.1M843.1M728.3M732.7M597.9M579.0M
Total assets2.59B2.56B2.70B2.64B2.29B2.26B2.03B1.88B1.59B1.56B
Accounts payable26.7M25.3M38.0M25.7M33.9M29.4M23.1M16.2M18.5M16.9M
Current liabilities163.7M175.8M159.4M128.5M176.0M152.3M106.7M102.0M79.5M135.5M
Long-term debt200.0M346.0M319.0M350.0M243.4M328.8M344.2M492.7M339.0M343.8M
Total debt289.1M444.1M419.5M455.0M12.5M12.5M12.5M12.5M347.9M349.9M
Total liabilities478.5M639.1M635.0M672.2M593.8M691.7M646.4M718.8M514.1M605.8M
Shareholders' equity2.11B1.92B2.07B1.97B1.70B1.56B1.38B1.17B1.08B949.6M
Shares outstanding156.1M155.0M158.2M157.6M156.6M39.0M38.5M37.9M37.6M37.4M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations292.1M287.6M299.0M254.4M325.3M352.2M205.2M181.6M170.4M143.7M
Capital spending-28.9M-31.0M-62.9M-38.2M-44.9M-44.3M-51.7M-25.4M-20.9M-15.2M
Free cash flow263.2M256.6M236.1M216.1M280.4M307.9M153.5M156.2M149.4M128.5M
Cash from investing-18.2M-35.2M-203.0M-265.6M-96.9M-243.5M27.1M-336.8M-38.7M-306.0M
Cash from financing-169.1M-253.9M-122.4M22.6M-242.9M-62.6M-183.8M134.4M-99.2M189.1M
Dividends paid-49.9M-50.4M-50.4M-50.3M-50.2M-49.6M-48.9M-48.4M-48.0M-47.3M
Share buybacks-41.7M-275.7M-80.0M-19.6M-160.9M-43.2M-50.1M-15.4M05.26M
Change in cash102.5M10.4M-28.8M8.00M-26.5M52.5M45.7M-21.1M30.4M27.4M

Open Financials

Filings

FilingDateTypeFiled with
10-Q/A · Quarterly report, amendedNov 12, 2026Quarterly reportSEC
10-Q · Quarterly reportNov 6, 2026Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 5, 2026Big-stake noticeSEC
8-K · Current reportNov 3, 2026Current reportSEC
4 · Change in ownershipNov 3, 2026Insider tradeSEC
4 · Change in ownershipNov 3, 2026Insider tradeSEC
4/A · Change in ownership, amendedNov 2, 2026Insider tradeSEC
4/A · Change in ownership, amendedNov 2, 2026Insider tradeSEC
4/A · Change in ownership, amendedNov 2, 2026Insider tradeSEC
4/A · Change in ownership, amendedNov 2, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipNov 2, 2026Insider tradeSEC
4 · Change in ownershipNov 2, 2026Insider tradeSEC
4 · Change in ownershipNov 2, 2026Insider tradeSEC
4 · Change in ownershipNov 2, 2026Insider tradeSEC
4 · Change in ownershipNov 2, 2026Insider tradeSEC
4 · Change in ownershipNov 2, 2026Insider tradeSEC
4 · Change in ownershipNov 2, 2026Insider tradeSEC
4 · Change in ownershipNov 2, 2026Insider tradeSEC
10-K/A · Annual report, amendedOct 28, 2026Annual reportSEC
4 · Change in ownershipSep 30, 2026Insider tradeSEC
4 · Change in ownershipSep 24, 2026Insider tradeSEC
8-K · Current reportSep 23, 2026Meeting outcomeSEC
DEFA14A · Additional proxy materialSep 14, 2026Meeting noticeSEC
8-K · Current reportSep 14, 2026Current reportSEC
DEFA14A · Additional proxy materialSep 9, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 2, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialAug 25, 2026Meeting noticeSEC
10-K · Annual reportAug 24, 2026Annual reportSEC
DEFM14AAug 20, 2026Meeting noticeSEC
4 · Change in ownershipAug 19, 2026Insider tradeSEC
4 · Change in ownershipAug 19, 2026Insider tradeSEC
4 · Change in ownershipAug 19, 2026Insider tradeSEC
4 · Change in ownershipAug 19, 2026Insider tradeSEC
4 · Change in ownershipAug 19, 2026Insider tradeSEC
4 · Change in ownershipAug 19, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
8-K · Current reportAug 12, 2026ResultsSEC
PREM14AAug 10, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 6, 2026Big-stake noticeSEC
4 · Change in ownershipJul 31, 2026Insider tradeSEC
4 · Change in ownershipJul 30, 2026Insider tradeSEC
4 · Change in ownershipJul 27, 2026Insider tradeSEC
DEFA14A · Additional proxy materialJul 9, 2026Meeting noticeSEC
8-K · Current reportJun 25, 2026Material contractSEC
DEFA14A · Additional proxy materialJun 25, 2026Meeting noticeSEC
8-K · Current reportJun 25, 2026Current reportSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
SD · Specialized disclosureJun 1, 2026ESG reportSEC
4 · Change in ownershipMay 12, 2026Insider tradeSEC
144 · Notice of proposed saleMay 8, 2026Other filingsSEC
4 · Change in ownershipMay 7, 2026Insider tradeSEC
4 · Change in ownershipMay 7, 2026Insider tradeSEC
4 · Change in ownershipMay 7, 2026Insider tradeSEC
10-Q · Quarterly reportMay 6, 2026Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeMay 6, 2026Big-stake noticeSEC
8-K · Current reportMay 6, 2026ResultsSEC
4 · Change in ownershipMay 5, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeApr 29, 2026Big-stake noticeSEC
4 · Change in ownershipApr 24, 2026Insider tradeSEC
4 · Change in ownershipApr 24, 2026Insider tradeSEC
4 · Change in ownershipApr 16, 2026Insider tradeSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 17, 2026Other filingsSEC
8-K · Current reportFeb 11, 2026Management or board changeSEC
4 · Change in ownershipFeb 5, 2026Insider tradeSEC
10-Q · Quarterly reportFeb 4, 2026Quarterly reportSEC
8-K · Current reportFeb 4, 2026ResultsSEC
4 · Change in ownershipFeb 3, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
4 · Change in ownershipNov 5, 2025Insider tradeSEC
4 · Change in ownershipNov 5, 2025Insider tradeSEC
4 · Change in ownershipNov 5, 2025Insider tradeSEC
10-Q · Quarterly reportNov 5, 2025Quarterly reportSEC
8-K · Current reportNov 5, 2025ResultsSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
ARS · Annual report to shareholdersSep 19, 2025Annual reportSEC
DEFA14A · Additional proxy materialSep 19, 2025Meeting noticeSEC
DEF 14A · Proxy statementSep 19, 2025Meeting noticeSEC
4 · Change in ownershipAug 27, 2025Insider tradeSEC
4 · Change in ownershipAug 27, 2025Insider tradeSEC
144 · Notice of proposed saleAug 25, 2025Other filingsSEC
144 · Notice of proposed saleAug 25, 2025Other filingsSEC
10-K · Annual reportAug 22, 2025Annual reportSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
4 · Change in ownershipAug 11, 2025Insider tradeSEC
8-K · Current reportAug 6, 2025ResultsSEC
4 · Change in ownershipJul 31, 2025Insider tradeSEC
4 · Change in ownershipJul 24, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 16, 2025Big-stake noticeSEC
4 · Change in ownershipJun 11, 2025Insider tradeSEC
144 · Notice of proposed saleJun 9, 2025Other filingsSEC
SD · Specialized disclosureMay 30, 2025ESG reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 7, 2025ResultsSEC
8-K · Current reportMay 6, 2025Current reportSEC
4 · Change in ownershipMay 5, 2025Insider tradeSEC
4/A · Change in ownership, amendedApr 11, 2025Insider tradeSEC
4 · Change in ownershipApr 7, 2025Insider tradeSEC
8-K · Current reportMar 4, 2025Management or board changeSEC
4 · Change in ownershipFeb 18, 2025Insider tradeSEC
144 · Notice of proposed saleFeb 14, 2025Other filingsSEC
4 · Change in ownershipFeb 7, 2025Insider tradeSEC
3 · Initial statement of ownershipFeb 7, 2025Insider tradeSEC
10-Q · Quarterly reportFeb 6, 2025Quarterly reportSEC
8-K · Current reportFeb 5, 2025ResultsSEC
4 · Change in ownershipFeb 4, 2025Insider tradeSEC
4 · Change in ownershipFeb 4, 2025Insider tradeSEC
4/A · Change in ownership, amendedFeb 3, 2025Insider tradeSEC
4 · Change in ownershipJan 29, 2025Insider tradeSEC
144 · Notice of proposed saleJan 27, 2025Other filingsSEC
SC 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 8, 2024Big-stake noticeSEC
4 · Change in ownershipNov 5, 2024Insider tradeSEC
4 · Change in ownershipNov 5, 2024Insider tradeSEC
4 · Change in ownershipNov 5, 2024Insider tradeSEC
8-K · Current reportNov 5, 2024Management or board changeSEC
10-Q · Quarterly reportNov 5, 2024Quarterly reportSEC
8-K · Current reportOct 30, 2024ResultsSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedOct 21, 2024Big-stake noticeSEC
4 · Change in ownershipSep 16, 2024Insider tradeSEC
ARS · Annual report to shareholdersSep 12, 2024Annual reportSEC
DEFA14A · Additional proxy materialSep 12, 2024Meeting noticeSEC
DEF 14A · Proxy statementSep 12, 2024Meeting noticeSEC
4 · Change in ownershipSep 3, 2024Insider tradeSEC
10-K · Annual reportAug 22, 2024Annual reportSEC
4 · Change in ownershipAug 19, 2024Insider tradeSEC
4 · Change in ownershipAug 19, 2024Insider tradeSEC
4 · Change in ownershipAug 19, 2024Insider tradeSEC
4 · Change in ownershipAug 19, 2024Insider tradeSEC
4 · Change in ownershipAug 19, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
144 · Notice of proposed saleAug 8, 2024Other filingsSEC
8-K · Current reportAug 7, 2024ResultsSEC
4 · Change in ownershipAug 6, 2024Insider tradeSEC
4 · Change in ownershipAug 2, 2024Insider tradeSEC
4 · Change in ownershipJul 25, 2024Insider tradeSEC
4 · Change in ownershipJul 10, 2024Insider tradeSEC
SD · Specialized disclosureMay 31, 2024ESG reportSEC
4 · Change in ownershipMay 16, 2024Insider tradeSEC
144 · Notice of proposed saleMay 14, 2024Other filingsSEC
10-Q · Quarterly reportMay 6, 2024Quarterly reportSEC
4 · Change in ownershipMay 3, 2024Insider tradeSEC
3 · Initial statement of ownershipMay 3, 2024Insider tradeSEC
8-K · Current reportMay 1, 2024ResultsSEC
8-K · Current reportApr 30, 2024Management or board changeSEC
4 · Change in ownershipApr 5, 2024Insider tradeSEC
4 · Change in ownershipMar 11, 2024Insider tradeSEC
144 · Notice of proposed saleMar 7, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
10-Q · Quarterly reportFeb 7, 2024Quarterly reportSEC
4 · Change in ownershipFeb 5, 2024Insider tradeSEC
4 · Change in ownershipFeb 5, 2024Insider tradeSEC
3 · Initial statement of ownershipFeb 5, 2024Insider tradeSEC
4 · Change in ownershipFeb 5, 2024Insider tradeSEC
8-K · Current reportFeb 1, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedJan 24, 2024Big-stake noticeSEC
8-K · Current reportJan 8, 2024Management or board changeSEC
4 · Change in ownershipDec 21, 2023Insider tradeSEC
4/A · Change in ownership, amendedDec 14, 2023Insider tradeSEC
4/A · Change in ownership, amendedDec 14, 2023Insider tradeSEC
4/A · Change in ownership, amendedDec 14, 2023Insider tradeSEC
4/A · Change in ownership, amendedDec 14, 2023Insider tradeSEC
4/A · Change in ownership, amendedNov 9, 2023Insider tradeSEC
10-Q · Quarterly reportNov 7, 2023Quarterly reportSEC
4 · Change in ownershipNov 3, 2023Insider tradeSEC
4 · Change in ownershipNov 3, 2023Insider tradeSEC
4 · Change in ownershipNov 3, 2023Insider tradeSEC
8-K · Current reportOct 31, 2023ResultsSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Bio-Techne Corp’s releases · as of Oct 9, 2026

Common shares
157,055,564
Fully diluted
157,055,564

Fully diluted

LineSharesAs of
Common shares157,055,564Oct 9, 2026

Share count over time

CountShares
Oct 9, 2026157,055,564

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
Vanguard18M11.5%US$1.31B−109KNov 16, 2026
BlackRock14.3M9.1%US$1.03B+225KNov 13, 2026
Hbk Investments L P7.73M4.9%US$560M+907KNov 16, 2026
FIL Ltd6.27M4.0%US$455M+6.27MNov 10, 2026
State Street6.05M3.8%US$438M+65,514Nov 12, 2026
Geode Capital5.43M3.5%US$393M+80,432Nov 6, 2026
Goldman Sachs4.14M2.6%US$300M−3.2MNov 16, 2026
Millennium4.09M2.6%US$297M+3.1MNov 16, 2026
Invesco3.78M2.4%US$274M−1.21MNov 12, 2026
Balyasny Asset Management L.P.3.4M2.2%US$247M+2.57MNov 16, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Ruane, Cunniff & Goldfarb L.P.3.34M2.1%US$242M−6,004Nov 13, 2026
Morgan Stanley3.33M2.1%US$241M−3.05MNov 13, 2026
UBS2.99M1.9%US$217M−25,168Nov 16, 2026
Whitebox Advisors LLC2.62M1.7%US$190M+524KNov 16, 2026
D. E. Shaw & Co., Inc.2.53M1.6%US$183M+2.3MNov 16, 2026
Qube Research & Technologies Ltd2.38M1.5%US$172MNewNov 13, 2026
Sun Life2.32M1.5%US$168M−425KNov 12, 2026
Neuberger Berman Group LLC2.26M1.4%US$164M−587KNov 13, 2026
Barclays2.25M1.4%US$163M+2.03MNov 6, 2026
Citigroup Inc1.76M1.1%US$128M+1.32MNov 4, 2026
JPMorgan1.69M1.1%US$123M−171KNov 12, 2026
Schwab1.68M1.1%US$122M+57,388Nov 16, 2026
Maverick Capital LTD1.54M0.98%US$111MNo changeNov 16, 2026
Arrowstreet Capital, Limited Partnership1.37M0.88%US$99.6M+1.13MNov 13, 2026
First Trust1.31M0.83%US$94.9M−64,344Nov 12, 2026
AQR Arbitrage LLC1.29M0.82%US$93.6M+532KNov 16, 2026
Mairs & Power Inc1.27M0.81%US$92.3M−1.43MNov 16, 2026
Northern Trust1.26M0.80%US$91.3M−51,437Nov 16, 2026
DWS1.23M0.78%US$89.1M+527KNov 6, 2026
Glazer Capital, LLC1.15M0.73%US$83.5M+952KNov 16, 2026
Brown Advisory Inc1.09M0.69%US$79.1M−197KNov 16, 2026
Fidelity1.09M0.69%US$78.9M−11.7MNov 10, 2026
Madison Asset Management, LLC1.02M0.65%US$73.7M−46,082Nov 12, 2026
AllianceBernstein1.01M0.64%US$73.3M−990KNov 16, 2026
Bank of America942K0.60%US$68.2M−13,503Nov 16, 2026
Capital Group937K0.60%US$67.9M−1.68MNov 12, 2026
Natixis Advisors, LLC920K0.59%US$66.7M+101KNov 13, 2026
Jones Financial Companies Lllp919K0.59%US$66.7M+122KNov 13, 2026
BNY915K0.58%US$66.3M−363KNov 5, 2026
TIG Advisors, LLC892K0.57%US$64.6M+49,708Nov 16, 2026
Geneva Capital Management LLC884K0.56%US$64.1M−128KNov 9, 2026
Tudor Investment Corp Et Al856K0.54%US$62M−87,538Nov 16, 2026
Man Group plc770K0.49%US$55.8M+410KNov 16, 2026
Magnetar Financial LLC762K0.49%US$55.2MNo changeNov 13, 2026
Df Dent & Co Inc745K0.47%US$54M−285KNov 16, 2026
TD743K0.47%US$53.9M+694KNov 16, 2026
Squarepoint Ops LLC612K0.39%US$44.4M+521KNov 9, 2026
Jane Street612K0.39%US$44.3M+607KNov 12, 2026
CIBC586K0.37%US$42.5M+476KNov 13, 2026
Dimensional582K0.37%US$42.1M−1.67MNov 4, 2026

This page holds 50 of 571 holders. Open Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
Fidelity Contrafund4.99M3.2%US$353M+3.05MJun 30, 2026
Vanguard Total Stock Market Index Fund4.97M3.2%US$351M−10,261Jun 30, 2026
Vanguard 500 Index Fund4.06M2.6%US$287M+84,211Jun 30, 2026
SMALLCAP World Fund Inc3.59M2.3%US$254M+701KJun 30, 2026
Vanguard Small-Cap Index Fund3.59M2.3%US$253M−20,807Jun 30, 2026
Invesco S&P 500 Equal Weight ETF3.55M2.3%US$256M+401KJul 31, 2026
Eaton Vance Atlanta Capital SMID-Cap Fund2.6M1.7%US$184M−1.37MJun 30, 2026
MFS Mid Cap Growth Fund2.33M1.5%US$120M+528KMay 31, 2026
iShares Core S&P 500 ETF2.16M1.4%US$153M+153KJun 30, 2026
Vanguard Small-Cap Growth Index Fund2.07M1.3%US$146M+51,171Jun 30, 2026
Show 50 holders
HolderSharesOf the companyValueChangeAs of
Fidelity 500 Index Fund2M1.3%US$103M+19,238May 31, 2026
Select Health Care Portfolio1.9M1.2%US$98.2M+1.8MMay 31, 2026
Neuberger Genesis Fund1.85M1.2%US$95.8M+69,361May 31, 2026
Select Medical Technology and Devices Portfolio1.64M1.0%US$84.8M+560KMay 31, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund1.57M1.00%US$81.1M+1.11MMay 31, 2026
Mairs & Power Fund1.41M0.89%US$99.3M−5,755Jun 30, 2026
Sequoia Fund Inc1.39M0.88%US$97.9M+82,417Jun 30, 2026
First Trust NYSE Arca Biotechnology Index Fund1.37M0.87%US$96.5M+139KJun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF1.11M0.70%US$78.1M−32,441Jun 30, 2026
iShares Biotechnology ETF1.11M0.70%US$78.1M−46,529Jun 30, 2026
Fidelity Contrafund K61.05M0.67%US$74.4M+640KJun 30, 2026
Nomura Mid Cap Growth Fund1.04M0.66%US$73.7M−191KJun 30, 2026
Vanguard Institutional Index Fund850K0.54%US$60.1M−33,253Jun 30, 2026
MFS New Discovery Fund678K0.43%US$35M+33,077May 31, 2026
Strategic Advisers U.S. Total Stock Fund659K0.42%US$34M−79,627May 31, 2026
iShares Russell Mid-Cap ETF642K0.41%US$45.4M+48,783Jun 30, 2026
Fidelity Mid Cap Index Fund592K0.38%US$42.7M+20,382Jul 31, 2026
Madison Mid Cap Fund485K0.31%US$34.9M−64,000Jul 31, 2026
Vanguard Health Care Index Fund468K0.30%US$24.2M+964May 31, 2026
Schwab U.S. Mid-Cap ETF424K0.27%US$21.9M+3,289May 31, 2026
Capital Group U.S. Small and Mid Cap ETF419K0.27%US$21.7M+270KMay 31, 2026
AB Discovery Value Fund413K0.26%US$29.2M−101KJun 30, 2026
U.S. Small Cap Portfolio383K0.24%US$27.6M+10,616Jul 31, 2026
Fidelity SAI Merger Arbitrage Fund376K0.24%US$27.1MNewJul 31, 2026
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF370K0.24%US$26.1M+39,232Jun 30, 2026
Touchstone Strategic Trust-Touchstone Small Company Fund361K0.23%US$25.5M+89,482Jun 30, 2026
Schwab S&P 500 Index Fund352K0.22%US$25.4M−2,918Jul 31, 2026
iShares Russell 1000 Value ETF350K0.22%US$24.7M−7,365Jun 30, 2026
Dimensional U.S. Core Equity 2 ETF329K0.21%US$23.7M+33,259Jul 31, 2026
Dimensional U.S. Small Cap ETF327K0.21%US$23.6M+36,599Jul 31, 2026
Bridge Builder Small/Mid Cap Growth Fund316K0.20%US$22.4M−492KJun 30, 2026
Fidelity U.S. Equity Central Fund300K0.19%US$21.2M−10,000Jun 30, 2026
Fidelity Total Market Index Fund299K0.19%US$15.5M+7,518May 31, 2026
Invesco S&P 500 Quality ETF293K0.19%US$21.1M+10,497Jul 31, 2026
Fidelity Balanced Fund285K0.18%US$14.7MNewMay 31, 2026
Champlain MidCap Fund275K0.18%US$19.4M−246KJun 30, 2026
BNY Mellon Small/Mid Cap Growth Fund274K0.17%US$19.3M−31,773Jun 30, 2026
Small-MidCap Dividend Income Fund262K0.17%US$13.5M−14,271May 31, 2026
iShares S&P 500 Value ETF259K0.16%US$18.3M−8,376Jun 30, 2026
Invesco Equally-Weighted S&P 500 Fund251K0.16%US$13M+31,582May 31, 2026

This page holds 50 of 546 holders. Open Shareholders

Insider trades

InsiderTradeSharesPriceValueDate
Herr Amy E.
Director
Sale6,636USD 48.28US$320KMay 8, 2026

Big stakes

HolderStakeSharesDate
Vanguard Capital Management LLC7.38%11.6MMar 31, 2026
BlackRock, Inc.7.00%11MJun 30, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Charles Kummeth
Other companies: Quantum-Si Incorporated (Chairman of the Board · Since at least May 27, 2024); Orthofix Medical Inc. (Director · Since at least Dec 14, 2023); Gentherm Inc (Member of the Board · Since at least Aug 1, 2018); Sparton Corporation (Director · Nov 11, 2011 – Mar 4, 2019 · Past)
Chief Executive Officer, Director · Apr 1, 2013 – Aug 15, 2023 · Past
John Higgins
Other companies: Immunome, Inc. (Chief Scientific Officer · Since at least Oct 2, 2023); OmniAb, Inc. (Board Chair · Since at least Nov 1, 2022); Ligand Pharmaceuticals Incorporated (Director · May 14, 2019 – Dec 28, 2022 · Past)
Director · Since at least Jun 4, 2019
Julie L. Bushman
Other companies: Phillips 66 (Director · Since at least Jul 8, 2020); Adient plc (Board Member · Since at least Oct 31, 2016); 3M Company (Executive Vice President · Jun 1, 2011 – Feb 4, 2020 · Past)
Director · Since at least Aug 3, 2020
Alpna Seth
Other companies: Keros Therapeutics, Inc. (Director · Since at least May 1, 2023); Seagen Inc (Director · Mar 15, 2018 – Dec 14, 2023 · Past)
Director · Since at least Oct 26, 2017
Joseph D. Keegan
Other companies: Interpace Biosciences, Inc. (Director · Since at least Jan 1, 2016); Stereotaxis, Inc. (Director · Feb 16, 2011 – May 24, 2016 · Past)
Director · Since at least Oct 26, 2017
Randolph C Steer
Other companies: Immunic, Inc. (Director · Apr 16, 2014 – May 23, 2017 · Past); Capstone Holding Corp. (President · Jan 17, 2011 – Jan 17, 2011 · Past)
Director · Oct 28, 2010 – Oct 26, 2023 · Past
Rupert Vessey
Other companies: Generate Biomedicines, Inc. (Director · Since at least Feb 26, 2026); Bristol-Myers Squibb Company (EVP & President, Research · Oct 30, 2020 – May 3, 2023 · Past)
Director · Since at least Oct 29, 2020
Brenda S Furlow
Other companies: TomoTherapy Inc (VP, General Counsel & Secr. · Aug 25, 2008 – Jun 10, 2011 · Past)
SVP - GENERAL COUNSEL · Aug 4, 2014 – Dec 7, 2022 · Past
Gregory J Melsen
Other companies: Janel Corp. (Director · Since at least Jan 2, 2018)
CFO · Jul 27, 2006 – Aug 1, 2013 · Past
Harold J Wiens
Other companies: 3M Company (EXEC VP TRANSPORTATION · Dec 31, 2005 – Dec 31, 2005 · Past)
Director · May 15, 2014 – May 22, 2020 · Past
All 32 people
PersonSeat
Judith Klimovsky
Other companies: Bellicum Pharmaceuticals Inc (Director · Dec 20, 2018 – Jan 3, 2023 · Past)
Director · Since at least Apr 24, 2024
Karen A Holbrook
Other companies: Huntington Bancshares Incorporated (Director · Jan 31, 2006 – Jan 4, 2007 · Past)
Director · Feb 12, 2007 – Sep 6, 2017 · Past
Kim Kelderman
Other companies: CONMED Corporation (Director · Since at least Sep 8, 2025)
Chief Executive Officer, Director · Since at least Apr 30, 2018
Matthew McManus
Other companies: Azenta, Inc. (EVP & Chief Operating Officer · Jan 24, 2022 – Aug 19, 2022 · Past)
President - Diag & Spatial Bio · Since at least Jan 8, 2024
Norman David Eansor
Other companies: Marker Therapeutics, Inc. (Director · Since at least May 9, 2019)
President-Protein Sciences · Jun 12, 2019 – Nov 12, 2021 · Past
Roger C Lucas
Other companies: ChemoCentryx Inc. (Director · Feb 8, 2012 – Mar 5, 2019 · Past)
Director · Feb 1, 2006 – Oct 10, 2017 · Past
Steven C Crouse
Other companies: OmniAb, Inc. (Director · Since at least Apr 21, 2025)
President - Diag & Spatial Bi · Since at least Mar 1, 2026
William Geist
Other companies: Quanterix Corporation (Chief Operating Officer · Nov 16, 2020 – Feb 8, 2021 · Past)
PRESIDENT, PROTEIN SCIENCES · Since at least Jan 3, 2022
Amy E. HerrDirector · Since at least Feb 1, 2025
Charles A DinarelloDirector · Oct 26, 2017 – Aug 8, 2018 · Past
David ClairVice President, Investor Relations · Since at least Nov 4, 2026
Howard V OconnellDirector · Feb 13, 2006 – Feb 19, 2015 · Past
James HippelCFO · Since at least Apr 1, 2014
J Fernando BazanChief Technical Officer · Aug 1, 2013 – Oct 26, 2017 · Past
Kevin J ReaganSenior VP - Biotech · Aug 1, 2013 – Dec 5, 2014 · Past
Monica TsangVP of Research · Feb 27, 2006 – May 3, 2007 · Past
Robert M GavinSen. VP Protein Platforms · Nov 25, 2014 – Oct 26, 2017 · Past
Robert V. BaumgartnerDirector · Since at least Feb 3, 2006
Roeland NusseDirector · Since at least May 26, 2010
Shane BohnenSVP - General Counsel · Since at least Mar 3, 2023
Steve CrousePresident, Diagnostics and Spatial Biology Segment · Since at least Feb 11, 2026
Thomas E OlandCEO, President, Director · Jan 31, 2006 – Nov 30, 2011 · Past

Open People

Log in to ask 6ix AI your own questions about Bio-Techne Corp.